Primary parotid lymphoma: the effect of international prognostic index on outcome

References

• Freeman C., Berg J. W., Cutler. Occurrence and prognosis of extranodal lymphomas. Cancer 1972; 29: 252–260
   PubMed Web of Science ®Google Scholar
• Chang C. H. Diseases of the salivary glands. Radiation Therapy, R. M. Rankow, I. Polayes. W. B. Saunders, Philadelphia. 1976
   Google Scholar
• Conley S. F., Staszak C., Clamon G. H., Maves M. D. Non-Hodgkin's lymphoma of the head and neck: the University of Iowa experience. Laryngoscope 1987; 97: 291–300
   PubMed Web of Science ®Google Scholar
• Beahrs O. H. Arch. Surg 1960; 80: 890–904
   PubMed Web of Science ®Google Scholar
• Patey D. H., Thachkray A. C., Keeling D. H. Malignant disease of the parotid. Br. J. Cancer 1965; 19: 712–737
   PubMed Web of Science ®Google Scholar
• Nussbaum M., Cho H. T., Som M. L. Parotid space tumors of non-salivary origin. Ann. Surg 1976; 183: 10–2
   PubMed Web of Science ®Google Scholar
• Spiro R., Spiro J. Cancer of the salivary glands. Cancer of the Head and Neck, E. Meyers, J. Suen. Churchill, Livingstone 1984
   Google Scholar
• Hyman G. A., Wolff M. Malignant lymphomas of the salivary glands. Review of the literature and report of 33 new caes, including four cases associated with the lymphoepithelial lesion. Am. J. Clin. Pahtol 1976; 65: 421–38
   PubMed Web of Science ®Google Scholar
• Sharkey F. E. Systematic evaluation of the World Health Organization classification of salivary gland tumors: a clinicopathologic study of 366 cases. Am. J. Clin. Pathol 1977; 67: 272–8
   PubMed Web of Science ®Google Scholar
• Wheelock M. C., Madden T. J. Uncommon tumors of the salivary glands. Surg. Gynecol. Obstet 1948; 88: 776–783
   Google Scholar
• Simons J. N., Beahrs O. H., Woolner L. B. Tumors of the submaxillary gland. Am. J. Surg 1964; 108: 485–494
   PubMed Web of Science ®Google Scholar
• Eneroth C. M., Hjertman L., Moberger G. Malignant tumours of the submandibular gland. Acta Otolaryngol (Stockh) 1967; 64: 514–36
   PubMedGoogle Scholar
• Rafla S. Submaxillary gland tumors. Cancer 1970; 26: 821–6
   PubMed Web of Science ®Google Scholar
• Lipton A., Lee B. J. Prognosis of stage I lymphosarcoma and reticulum-cell sarcoma. N. Engl. J. Med 1971; 284: 230–3
   PubMed Web of Science ®Google Scholar
• Colby T. V., Dorfman R. F. Malignant lymphomas involving the salivary glands. Pathol. Annu 1979; 2: 307–24
   Google Scholar
• Gleeson M. J., Bennett M. H., Cawson R. A. Lymphomas of salivary glands. Cancer 1986; 58: 699–704
   PubMed Web of Science ®Google Scholar
• Batsakis J. G., Regezi J. A. Selected controversial lesions of salivary tissues. Otolaryngol. Clin. North Am 1977; 10: 309–28
   PubMed Web of Science ®Google Scholar
• Thomson A. S., Bryant H. C. Histogenesis of papillary cystadenoma lymphomatosum (Warthin's tumor) of the parotid gland. Am. J. Pathol 1950; 26: 807–849
   PubMed Web of Science ®Google Scholar
• Kassan S. S., Thomas T. L., Moutsopoulos H. M., Hoover R., Kimberly R. P., Budman D. R., Costa J., Decker J. L., Chused T. M. Increased risk of lymphoma in sicca syndrome. Ann. Intern. Med 1978; 89: 888–92
   PubMed Web of Science ®Google Scholar
• Zulman J., Jaffe R., Talal N. Evidence that the malignant lymphoma of Sjogren's syndrome is a monoclonal B-cell neoplasm. N. Engl. J. Med 1978; 299: 1215–20
   PubMed Web of Science ®Google Scholar
• Morgan W. S., Castleman B. A clinicophatologic study of “Mikulicz's disease”. Am. J. Pathol 1953; 29: 471–489
   PubMed Web of Science ®Google Scholar
• Nichols R. D., Rebuck J. W., Sullivan J. C. Lymphoma and the parotid gland. Laryngoscope 1982; 92: 365–9
   PubMed Web of Science ®Google Scholar
• Lichtenfeld J. L., Kirschner R. H., Wiernik P. H. Familial Sjogren's syndrome with associated primary salivary gland lymphoma. Am. J. Med 1976; 60: 286–92
   PubMed Web of Science ®Google Scholar
• Batsakis J. G., Bernacki E. G., Rice D. H., Stebler M. E. Malignancy and the benign lymphoepithelial lesion. Laryngoscope 1975; 85: 389–99
   PubMed Web of Science ®Google Scholar
• Schmid U., Helbron D., Lannert K. Primary malignant lymphomas localized in salivary glands. Histopathology 1982; 6: 673–87
   PubMed Web of Science ®Google Scholar
• Nime F. A., Cooper H. S., Eggleston J. C. Primary malignant lymphomas of the salivary glands. Cancer 1976; 37: 906–12
   PubMed Web of Science ®Google Scholar
• Hjorth L., Dommerby H., Kruse S., Nielsen A. Primary malignant lymphoma of the salivary glands. Tumori 1986; 72: 491–7
   PubMed Web of Science ®Google Scholar
• Shikhani A. Laryngoscope 1987; 17–21
   Web of Science ®Google Scholar
• Carbone P. P., Kaplan H. S., Musshoff K., Smithers D. W., Tubiana M. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 1971; 31: 1860–1
   PubMed Web of Science ®Google Scholar
• A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphpoma Prognostic Factors Project. N. Engl. J. Med 1993; 329: 987–94
   PubMed Web of Science ®Google Scholar
• Shipp M. A. Prognostic factors in aggressive non-Hodgkin's lymphoma: who has “high-risk” disease. Blood 1994; 83: 1165–73
   PubMed Web of Science ®Google Scholar
• National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer 1982; 49: 2112–35
   PubMed Web of Science ®Google Scholar
• Harris N. L., Jaffe E. S., Stein H., Banks P. M., Chan J. K., Cleary M. L., Delsol G., De Wolf-Peeters C., Falini B., Gatter K. C., Grogan T. M., Isaacson P. G., Knowles D. M., Mason D. Y., Muller-Hermelink H. K, Pileri S. A., Piris M. A., Ralfkiaer E., Warnke R. A. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–92
   PubMed Web of Science ®Google Scholar
• Kaplan E. L., Meier P. Non-parametric estimation from incomplete observations. J. Amer. Statistical. Assoc 1958; 53: 257–481
   Google Scholar
• Peto R., Peto J. Asymptotically efficient rank invariant (log rank) procedures. J. R. Stat. Soc 1972; 135: 185–207
   Google Scholar
• Seymour J. F., McLaughlin P., Fuller L., Hagemeister F. B., Hess M., Swan F., Romaguera J., Rodriguez M. A., Besa P., Cox J., Cabanillas F. High rate of prolonged remissions following combined modality therapy for patients with localized low-grade lymphoma. Annals of Oncology 1996; 7: 157–163
   PubMed Web of Science ®Google Scholar
• Wotherspoon A. C., Doglioni C., Diss T. C., Pan L., Moschini A., de Boni M., Isaacson P. G. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342: 575–7
   PubMed Web of Science ®Google Scholar
• Roggero E., Zucca E., Pinotti G., Pascarella A., Capella C., Savio A., Pedrinis E., Paterlini A., Venco A., Cavalli F. Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue. Ann. Intern. Med 1995; 122: 767–9
   PubMed Web of Science ®Google Scholar
• Portlock C. S., Rosenberg S. A., Glatstein E., Kaplan H. S. Treatment of advanced non-Hodgkin's lymphomas with favorable histologies: preliminary results of a prospective trial. Blood 1976; 47: 747–56
   PubMed Web of Science ®Google Scholar
• Portlock C. S., Rosenberg S. A. Combination chemotherapy with cyclophosphamide, vincristine, and prednisone in advanced non-Hodgkin's lymphomas. Cancer 1976; 37: 1275–82
   PubMed Web of Science ®Google Scholar
• McKelvey E. M., Gottlieb J. A., Wilson H. E., Haut A., Talley R. W., Stephens R., Lane M., Gamble J. F., Jones S. E., Grozea P. N., Gutterman J., Coltman C., Moon T. E. Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma. Cancer 1976; 38: 1484–93
   PubMed Web of Science ®Google Scholar
• McLaughlin P., Cabanillas F., Hagemeister F. B., Swan F., Jr, Romaguera J. E., Taylor S., Rodriguez M. A., Velasquez W. S., Redman J. R., Gutterman J. U. CHOP-Bleo plus interferon for stage IV low-grade lymphoma. Ann. Oncol 1993; 4: 205–11
   PubMed Web of Science ®Google Scholar
• Velasquez W. S., McLaughlin P., Fuller L. M., Allen P. K., Tucker S. L., Swan F. J., Rodriguez M. A., Hagemeister F. B., Cabanillas F. F. Intermediate-grade lymphomas treated with cyclophosphamide-doxorubicin-vincristine-prednisone-bleomycinal ternated with cyclophosphamide-methotrexate-etoposidedexamethasone. Application of prognostic models to data analysis. Cancer 1994; 73: 2408–16
   PubMed Web of Science ®Google Scholar
• McLaughlin P., Hagemeister F. B., Swan F., Cabanillas F., Romaguera J., Rodriguez M. A., Lee M. S., Pate O., Sarris A., Younes A. Intensive conventional-dose chemotherapy for stage IV low-grade lymphoma: High remission rates and reversion to negative of peripheral blood bcl-2 rearrangement. Ann. Oncol 1994; 2: 73–7
   Google Scholar
• Lee L., Cabanillas F. C., Bodey F. P., Freireich E. J. A 10 year update of CHOP-Bleo in the treatment of DLCL. J. Clin. Oncol 1985; 4: 1455–1461
   Web of Science ®Google Scholar
• Swan F. J., Velasquez W., Fuller L., Rodriguez A., McLaughlin P., Romaguera J., Redman J., Hagemeister F., Cabanillas F. Successful outcome of patients (pts) with good risk large cell lymphoma (LCL) with a shortened schedule of treatemet (RX). Proc. Amer. Soc. Clin. Oncol 1991; 10: 947a
   Google Scholar
• Velasquez W. S., Cabanillas F., Salvador P., McLaughlin P., Fridrik M., Tucker S., Jagannath S., Hagemeister F. B., Redman J. R., Swan F., et al. Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP). Blood 1988; 71: 117–22
   PubMed Web of Science ®Google Scholar
• Cabanillas F., Mc Laughlin P., Hagemeister F. B., Swan F., Rodriguez M. A., Romaguera J., Majlis A., Jendiroba D., Rodriguez J. Improvement in survival and disease-free survival of intermediate grade (IGL) and immunoblastic lymphomas (IBL) treated with a novel ATT 1994
   Google Scholar